Hi-Clearance Cash Flow Conversion Efficiency

Latest as of September 2025: 0.036x

Hi-Clearance cash flow conversion efficiency. Based on the latest financial reports, Hi-Clearance (1788) has a cash flow conversion efficiency ratio of 0.036x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$106.14 Million ≈ $3.34 Million USD) by net assets (NT$2.96 Billion ≈ $93.29 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Hi-Clearance (2015–2024)

Cash flow conversion efficiency of Hi-Clearance from 2015 to 2024. This chart illustrates how Hi-Clearance's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Hi-Clearance (1788) share price today for real-time trading data and today's change.

Hi-Clearance Cash Flow Conversion Ratio Explained

Hi-Clearance cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Hi-Clearance Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hi-Clearance ranked by their cash flow conversion efficiency. Also see 1788 company net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Wismilak Inti Makmur Tbk
JK:WIIM
0.040x
Tunas Baru Lampung Tbk
JK:TBLA
-0.100x
Anhui Yuanchen Environmental Protection Science & Technology Co. Ltd.
SHG:688659
0.002x
Aekyung Industrial Co Ltd
KO:018250
-0.005x
Proem Acquisition Corp I
NASDAQ:PAAC
-0.001x
Adgar Investments and Development Ltd
TA:ADGR
0.019x
MIRC Electronics Limited
NSE:MIRCELECTR
-0.255x
Monument Mining Limited
V:MMY
0.113x

Annual Cash Flow Conversion Efficiency for Hi-Clearance (2015–2024)

The table below shows the annual cash flow conversion efficiency of Hi-Clearance from 2015 to 2024. Review free cash flow generation of Hi-Clearance to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 NT$3.00 Billion
≈ $94.58 Million
NT$510.12 Million
≈ $16.07 Million
0.170x +16.97%
2023-12-31 NT$2.98 Billion
≈ $94.01 Million
NT$433.49 Million
≈ $13.66 Million
0.145x -12.09%
2022-12-31 NT$2.44 Billion
≈ $76.86 Million
NT$403.16 Million
≈ $12.70 Million
0.165x +32.30%
2021-12-31 NT$2.30 Billion
≈ $72.58 Million
NT$287.79 Million
≈ $9.07 Million
0.125x -39.13%
2020-12-31 NT$2.01 Billion
≈ $63.42 Million
NT$413.16 Million
≈ $13.02 Million
0.205x +42.69%
2019-12-31 NT$1.78 Billion
≈ $56.22 Million
NT$256.67 Million
≈ $8.09 Million
0.144x -24.88%
2018-12-31 NT$1.64 Billion
≈ $51.70 Million
NT$314.23 Million
≈ $9.90 Million
0.191x +28.21%
2017-12-31 NT$1.63 Billion
≈ $51.20 Million
NT$242.70 Million
≈ $7.65 Million
0.149x -29.06%
2016-12-31 NT$1.56 Billion
≈ $49.09 Million
NT$328.02 Million
≈ $10.33 Million
0.211x +549.74%
2015-12-31 NT$1.53 Billion
≈ $48.08 Million
NT$49.45 Million
≈ $1.56 Million
0.032x --

About Hi-Clearance

TWO:1788 Taiwan Medical Devices
Market Cap
$177.44 Million
NT$5.63 Billion TWD
Market Cap Rank
#16815 Global
#825 in Taiwan
Share Price
NT$126.50
Change (1 day)
-0.39%
52-Week Range
NT$126.50 - NT$138.00
All Time High
NT$149.30
About

Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and RO machines, and related consumables and drugs; interventional cardiology and radiology, and vascular surgery devices; dental consumables, implant materials, and equipment; and blood glucose monitors, and related consumabl… Read more